COVID VACCINE REMINDER FALL 2023. A new vaccination campaign against Covid-19 will be launched on October 2 for those most at risk of developing a serious form. Indications, date, deadline: know everything.
A new vaccination campaign against Covid-19 will be launched on October 2. There date has been brought forward (the campaign was to start on October 17) by the Minister of Health “in view of the current epidemiological circumstances” explained the General Directorate of Health on September 15. The two vaccination campaigns against Covid-19 and against the flu will thus be carried out in a manner joint.
A 6th dose of vaccine against Covid?
For certain people, the booster dose administered during the fall of 2023 will correspond to a 6th dose of vaccine against Covid. These people thus received 2 doses during the primary vaccination Then 3 reminders And 1 more from October 2. In fact, today, health authorities no longer speak in doses: “The notions of primary vaccination and booster vaccination are no longer relevant for people aged 5 and over (it’s different for young children, editor’s note). Regardless of the patient’s vaccination history, the dosage now consists of a single dose of vaccine. details the DGS in the letter of September 15.
Who should get a vaccine booster in fall 2023?
There immune protection decreases more quickly over time at the house of certain categories of people, further exposing them to the risk of developing a serious form of Covid-19. Are thus affected by a new booster dose of Covid-19 vaccine in the fall:
- All people aged 65 and over;
- People, aged over 6 months, with comorbidities having a higher risk of serious form of the disease (complicated arterial hypertension, heart, vascular, hepatic, renal, pulmonary problems, diabetes, obesity, cancers, transplanted people, people with Down syndrome or psychiatric disorders or dementia);
- Immunocompromised people;
- Pregnant women ;
- Residents in accommodation establishments for dependent elderly people (EHPAD) and long-term care units (USLD);
- People at very high risk of serious illness according to each individual medical situation and as part of a decision shared with the healthcare teams;
- People living in close proximity to or in regular contact with immunocompromised or vulnerable people, including professionals in the health and medicosocial sectors.
A deadline of 3 or 6 months must be respected depending on the case.
Populations affected by the vaccination campaign this fall are eligible from 6 months after their last infection or injection of vaccine against Covid-19. This deadline is reduced to 3 months for the people immunocompromisedwho thus become eligible, 3 months after their last injection, due to their immunodeficiency responsible for a lower level and a more rapid decline of protective antibodies.
What vaccines are administered for the booster dose?
For this campaign, vaccines adapted to the XBB.1.5 variant will be used preferentially. These include the new monovalent Comirnaty® Omicron XBB.1.5 vaccine developed by Pfizer/BioNTech.
Its Marketing Authorization was approved on August 31, 2023 by the European Medicines Agency. This vaccine was designed to target the XBB.1.5 sublineage of the Omicron variant, which is the majority circulating variant in the territory, but it remains also effective on the original Wuhan strainas well as on other variants.